mural nodule
Recently Published Documents


TOTAL DOCUMENTS

113
(FIVE YEARS 29)

H-INDEX

14
(FIVE YEARS 1)

Author(s):  
Abhilasha Rana ◽  
Ankita Aggarwal ◽  
Lekhraj Bairwa ◽  
Vishnu Prasad

Author(s):  
Gyani J. S. Birua ◽  
Gaurav Tyagi ◽  
Manish Beniwal ◽  
Dwarakanath Srinivas ◽  
Shilpa Rao

AbstractParenchymal perianeurysmal cysts are rare. We report a case of 50-year-old woman who presented with persistent headaches and episodes of vomiting for the last 2 months. Magnetic resonance imaging of the brain showed a well-defined solitary cystic lesion with a mural nodule measuring 5.4 × 5.2 × 4.6 cm in the right basifrontal region. The mural nodule was cortically based. It was hypointense on T2-weighted fluid-attenuated inversion recovery and showed intense contrast enhancement with few nonenhancing areas—no evidence of diffusion restriction. The cyst wall was nonenhancing, and magnetic resonance angiogram was unremarkable. Differential diagnoses included intra-axial gliomas such as ganglioglioma and pleomorphic xanthoastrocytoma. Right pterional craniotomy and a transcortical approach were made. Subtotal excision of cyst and clipping of right middle cerebral artery bifurcation thrombosed aneurysm were done. After 6 months of follow-up, patient is stable without any deficits. A parenchymal perianeurysmal cyst is a rare entity; it is crucial to be considered a differential diagnosis in any cystic lesion with the mural nodule.


2021 ◽  
pp. 1-9
Author(s):  
Shuji Suzuki ◽  
Mitsugi Shimoda ◽  
Jiro Shimazaki ◽  
Yukio Oshiro ◽  
Kiyotaka Nishda ◽  
...  

<b><i>Introduction:</i></b> This study aimed to determine the preoperative clinicophysiological and postoperative clinicopathological predictors of malignancy in patients with intraductal papillary mucinous neoplasm (IPMN). <b><i>Methods:</i></b> This was a retrospective observational study. We included 121 patients (73 men and 48 women; mean age: 68.7 years) who had undergone pancreatic resection for IPMN between 2007 and 2018. These patients were grouped into invasive carcinoma (IPMN-INV, <i>N</i> = 21) and low/high-grade IPMN (IPMN-LG/HG, <i>N</i> = 100) groups. Univariate and multivariate analyses of clinicophysiological parameters were carried out. These parameters were also compared between the IPMN-INV/HG (<i>N</i> = 53) and IPMN-LG (<i>N</i> = 68) groups. Survival analyses according to macroscopic type and IPMN subtypes were performed. <b><i>Results:</i></b> On univariate analysis, age (<i>p</i> = 0.038), carbohydrate antigen (CA) 19-9 (<i>p</i> &#x3c; 0.001), IPMN macroscopic type (<i>p</i> = 0.001), IPMN subtype (<i>p</i> &#x3c; 0.001), pancreatic duct diameter (<i>p</i> &#x3c; 0.001), and mural nodule (<i>p</i> = 0.042), between IPMN-INV and IPMN-LG/HG were found to be significant prognostic factors of malignancy. CA 19-9 was found to be an independent prognostic factor of IPMN malignancy on multivariate analysis (<i>p</i> = 0.035). The 1-, 3-, and 5-year overall survival (OS) rates of the IPMN-INV and IPMN-LG/HG groups were 94.4/100%, 94.4/100%, and 67.2/100%, respectively. The OS rate in the IPMN-LG/HG group was significantly higher than that in the IPMN-INV group (<i>p</i> &#x3c; 0.001). On univariate analysis, platelet (<i>p</i> = 0.043), CA 19-9 (<i>p</i> = 0.039), prognostic nutritional index (<i>p</i> = 0.034), platelet/lymphocyte ratio (<i>p</i> = 0.01), IPMN macroscopic type (<i>p</i> &#x3c; 0.001), IPMN subtype (<i>p</i> &#x3c; 0.001), pancreatic duct diameter (<i>p</i> = 0.036), and mural nodule (<i>p</i> = 0.032) between IPMN-INV/HG and IPMN-LG were found to be significant prognostic factors of malignancy. On multivariate analysis, CA 19-9 was found to be an independent prognostic factor (<i>p</i> = 0.042) between IPMN-INV/HG and IPMN-LG of malignancy. The 1-, 3-, and 5-year OS rates of the IPMN-INV/HG and IPMN-LG groups were 97.9/100%, 97.9/100%, and 82.6/100%, respectively. The OS rate was significantly higher in the IPMN-LG group than in the IPMN-INV/HG group (<i>p</i> = 0.03). No significant differences in survival were observed in patients with macroscopic tumors (<i>p</i>= 0.544). <b><i>Conclusion:</i></b> CA 19-9 is an independent invasive malignancy predictor of IPMN.


2021 ◽  
Author(s):  
Chen Wang ◽  
Tingting Lin ◽  
Xinru Wang ◽  
Zhicheng Yu ◽  
Xiaoling Zhuge ◽  
...  

Abstract Background: Intraductal papillary mucinous neoplasms (IPMNs) has the potential of malignant transformation. Previous studies showed that HDL-c was related to risk of cancer. In this study, we showed the association between HDL-c and the incidence of malignancy in IPMNs.Material and methods: 226 patients with histologically proven IPMNs who underwent surgery were included in the present study. 151 patients were assigned to training group andother 75 patients was set as a validation. Patients’ demographic information, clinical data, and pathological features were obtained from medical records. Those with high grade dysplasia and invasive carcinoma were defined as malignant IPMNs. Logistic regression analyses were used to show the association between HDL-cand malignant IPMNs. Receiver operating characteristic (ROC) curves were performed to show the predictive performance. Results: Prevalence of low HDL-c in patients with malignant IPMNs was higher than those with non-malignant IPMNs (p < 0.01) both in training group and validation group. Prevalence of malignant IPMNs was decreased with the increase of HDL-c both in all IPMNs and Branch-Duct IPMNs (BD-IPMNs).Logistic analysis showed that low HDL-c was associated with malignant IPMNs (OR =20.56, 95% CI:2.58 - 163.64) in all IPMNs and BD-IPMNs (OR = 17.6, 95%CI: 1.16-268.46).The predictive performance of mural nodule plus low HDL-c was higher than that of mural nodule alone or mural nodule plus cyst size in identifying malignant BD-IPMNs.Conclusion: HDL-c may be a potential biomarker for identifying malignant IPMNs. Moreover, HDL-c may improve the predictive ability of malignancy in BD-IPMNs.


2021 ◽  
Vol 12 ◽  
pp. 368
Author(s):  
Abiodun Idowu Okunlola ◽  
Ajayi Adeleke Ibijola ◽  
Olakunle Fatai Babalola ◽  
Cecilia Kehinde Okunlola ◽  
Olagoke Olaseinde Erinomo

Background: Cystic meningioma is a rare variety with similar histological profiles like the solid tumors. It has been documented in both supratentorial and infratentorial compartments presenting radiologically as a large cyst with mural nodule mimicking hemangioblastoma. Case Description: We managed a middle-aged woman who presented with recurrent seizures and brain MRI revealed left frontal cystic parasagittal tumor with mural nodule. She had left frontal awake craniotomy and gross total tumor excision. Histology confirmed meningothelial meningioma. Conclusion: Cystic meningioma is rare but should be high in differentials of cystic intracranial tumor with dural based nodules. Awake craniotomy is possible for the excision of parasagittal tumor most especially when it is frontal in location.


2021 ◽  
Vol 12 ◽  
pp. 368
Author(s):  
Abiodun Idowu Okunlola ◽  
Ajayi Adeleke Ibijola ◽  
Olakunle Fatai Babalola ◽  
Cecilia Kehinde Okunlola ◽  
Olagoke Olaseinde Erinomo

Background: Cystic meningioma is a rare variety with similar histological profiles like the solid tumors. It has been documented in both supratentorial and infratentorial compartments presenting radiologically as a large cyst with mural nodule mimicking hemangioblastoma. Case Description: We managed a middle-aged woman who presented with recurrent seizures and brain MRI revealed left frontal cystic parasagittal tumor with mural nodule. She had left frontal awake craniotomy and gross total tumor excision. Histology confirmed meningothelial meningioma. Conclusion: Cystic meningioma is rare but should be high in differentials of cystic intracranial tumor with dural based nodules. Awake craniotomy is possible for the excision of parasagittal tumor most especially when it is frontal in location.


2021 ◽  
Vol 49 (5) ◽  
pp. 030006052110131
Author(s):  
Tingting Sun ◽  
Liming Tian ◽  
Yunyun Guo ◽  
Yu Zheng ◽  
Linglong Ouyang ◽  
...  

Anaplastic carcinoma in an ovarian tumor (ACOT) is rare. There have been a few controversial cases illustrating the clinical characteristics and prognostic factors of ACOT, which are not well known. A 60-year-old Chinese woman presented with a large pelvic tumor. A transvaginal ultrasound examination showed a large single ovarian cystic tumor with mural nodules and ascites. A gross ovarian mass with a size of approximately 20 × 10×15 cm3 was found. The content of the ovarian cyst was light yellow and chocolate-like, and a large grayish mural nodule of approximately 10 cm was found on the cyst wall. Histological diagnosis of ovarian mucinous borderline cystadenoma with a mural nodule of anaplastic carcinoma showing rhabdoid features and International Federation of Gynecology and Obstetrics (FIGO) stage IIIa was made. Fifteen months after surgery, the patient had received six courses of paclitaxel and carboplatin. She is still alive without any recurrence of the tumor. Findings from the present case suggest that patients with ACOT and FIGO stage IIIa would benefit from surgery and chemotherapy of paclitaxel and carboplatin. We also review the clinical features and survival rate of patients with ACOT using the Surveillance, Epidemiology, and End Result database, and summarize previously reported treatments.


Sign in / Sign up

Export Citation Format

Share Document